Lower serum endocan levels are associated with the development of acute lung injury after major trauma

Journal of Critical Care

Volumn 27, Issue 5, 2012, Pages 522.e11-522.e17

  Mikkelsen, Mark E ^a   Shah, Chirag V ^a   Scherpereel, Arnaud ^b   Lanken, Paul N ^a   Lassalle, Philippe ^b   Bellamy, Scarlett L ^a   Localio, A Russell ^a   Albelda, Steven M ^a   Meyer, Nuala J ^a   Christie, Jason D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Biomarkers; Endothelium; Trauma

Indexed keywords

ENDOCAN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCAN BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CELL; INCIDENCE; INJURY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 84867334588     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.07.077     Document Type: Article

References (30)

1. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
2. Shah C.V., Localio A.R., Lanken P.N., et al. The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med 2008, 36:2309-2315.
3. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
4. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349.
5. Lassalle P., Molet S., Janin A., et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996, 271:20458-20464.
6. Bechard D., Meignin V., Scherpereel A., et al. Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res 2000, 37:417-425.
7. Bechard D., Gentina T., Delehedde M., et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem 2001, 276:48341-48349.
8. Bechard D., Scherpereel A., Hammad H., et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a-CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 2001, 167:3099-3106.
9. Repine J.E., Beehler C.J. Neutrophils and the adult respiratory distress syndrome: two interlocking perspective. Am Rev Respir Dis 1991, 144:251-252.
10. Martin T.R. Leukocyte migration and activation in the lungs. Eur Respir J 1997, 10:770-771.
11. Woodward M. Epidemiology: study design and data analysis 2005, Chapman & Hall, Boca Raton (Fla). 2nd ed.
12. Civil I.D., Schwab C.W. The abbreviated injury scale, 1985 revision: a condensed chart for clinical use. J Trauma 1988, 28:87-90.
13. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
14. Scherpereel A., Depontieu F., Grigoriu B., et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med 2006, 34:532-537.
15. Shah C.V., Bellamy S., Localio A.R., et al. Trajectory patterns of acute lung injury after major trauma. Am J Respir Crit Care Med 2008, 177:A629.
16. Christie J.D., Gaughan C., Gallop R., et al. Clinical risk factors of development of ARDS in a cohort study of patients with major trauma. Am J Respir Crit Care Med 2003, 167:A740.
17. Netzer G., Shah C., Iwashyna T., et al. Association of red cell transfusion with mortality in patients with acute lung injury. Chest 2007, 132:1116-1123.
18. Gong M.N., Thompson B.T., Williams P., et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005, 33(6):1191-1198.
19. Moss M., Bucher B., Moore F.A., et al. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome. JAMA 1996, 275:50-54.
20. Moss M., Guidot D.M., Steinberg K.P., et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000, 28:2187-2192.
21. Statistical software, release 10.0 2008, Stata Corporation, College Station (Tex).
22. Peduzzi P., Concato J., Kemper E., et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996, 49:1373-1379.
23. Marik P.E., Corwin H.L. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008, 36(11):3080-3084.
24. Khan S.Y., Kelher M.R., Heal J.M., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108:2455-2462.
25. De Freitas Caires N., Barrier M., Sarrazin S., et al. Identification of cathepsin G in the generation of elastase-resistant fragment of the vascular endocan: involvement in the regulation of LFA-1-dependent cascade. Crit Care 2009, 13:P16.
26. Calfee C.S., Eisner M.D., Parsons P.E., et al. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009, 35(2):248-257.
27. Calfee C.S., Eisner M.D., Ware L.B., et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med 2007, 35:2243-2250.
28. Maldonado G., Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138:923-936.
29. Gajic O., Frutos-Vivar F., Esteban A., et al. Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 2005, 31:922-926.
30. Ware L.B., Eisner M.D., Thompson B.T., et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004, 170:766-772.